Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth

BACKGROUND: Plant biotechnology provides a valuable contribution to global health, in part because it can decrease the cost of pharmaceutical products. Breast cancer can now be successfully treated by a humanized monoclonal antibody (mAb), trastuzumab (Herceptin). A course of treatment, however, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Komarova, Tatiana V., Kosorukov, Vyacheslav S., Frolova, Olga Y., Petrunia, Igor V., Skrypnik, Ksenia A., Gleba, Yuri Y., Dorokhov, Yuri L.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048398/
https://www.ncbi.nlm.nih.gov/pubmed/21390232
http://dx.doi.org/10.1371/journal.pone.0017541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048398/
https://www.ncbi.nlm.nih.gov/pubmed/21390232
http://dx.doi.org/10.1371/journal.pone.0017541

Ejemplares similares